09.19.17
Silk Therapeutics has hired Eva Genel as Director of Research and Development, Skincare.
In this new role, Genel's key responsibilities include designing and assessing clean, skincare formulations, overseeing testing, while spearheading new innovation, and product development. Genel relocated from Paris, France and is now based in the company's Medford, MA, headquarters, reporting to Greg Altman, CEO of Silk Therapeutics.
"We are elated to have Eva join our team, leading R&D and innovation across our growing skincare portfolio," said Altman. "Eva's experience within the industry provides Silk Therapeutics an invaluable source of expertise to help us both strengthen our current portfolio, while helping to develop the next generation of liquid, silk-based skincare formulas. Lastly, her vast knowledge of European skincare regulations will also empower us to develop and test against a stricter set of standards, which already include those of the Environmental Working Group (EWG), providing customers clean product offerings with minimal ingredients."
Genel joins Silk Therapeutics with over 15 years of skincare and ingredient-testing experience. She most recently served as the director of formulation and development at Groupe Rocher. Here, she led formulation and development across a team of 50 scientists for Yves Rocher, the best-selling botanical-based cosmetic brand in France.
Photo: Linked In
